Clinical trial No longer in our active list Interventional Ages 18 and up

Using brain-computer interface technology to help stroke patients regain upper limb function

Official title: Study of Functional Electrical Stimulation With Assistive Support Driven by a Brain-Computer Interface on the Upper Limb Rehabilitation of Chronic Stroke Patients

Run by University of Essex · NCT06179745 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a new brain-computer interface can help stroke patients regain use of their arms by improving their rehabilitation process.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment32 (estimated)
SponsorUniversity of Essex
Academic / other
Locations1 site (Vipiteno, South Tyrol)
Trial IDNCT06179745 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 who have experienced a first stroke more than six months prior, resulting in severe paralysis of the upper limb.

Probably not a fit

Patients with conditions obstructing EEG acquisition or severe concomitant diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of a brain-computer interface (BCI) combined with functional electrical stimulation (FES) and an active hand orthosis on upper limb rehabilitation in chronic stroke patients. The study is multi-center, randomized, sham-controlled, and double-blind, focusing on the functional recovery of the upper limb and the underlying neural plasticity mechanisms. Participants will be divided into a study group, where the BCI triggers the assistive devices based on detected motor intent, and a control group, where the devices are triggered randomly. The aim is to enhance the efficacy of rehabilitation therapies by restoring the connection between motor commands and sensory feedback.

Why it matters

Potential benefit: If successful, this approach could significantly improve upper limb function in chronic stroke patients, enhancing their quality of life.

How similar studies have gone: Previous studies using BCI technology for rehabilitation have shown promise, but this specific combination of interventions is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* More than 18 years of age
* Victim of ischemic or haemorrhagic cerebrovascular accident (CVA)
* At least 6 months since occurrence of CVA. No upper limit on time since stroke is imposed
* First CVA
* Severe central paresis or complete paralysis of the upper limb, as quantified by a Medical Research Council (MRC) scale score ≤2 evaluated at the wrist and finger extension and flexion, and forearm flexion and extension Other concomitant motor disabilities do not constitute exclusion criteria.
* Unilateral cortical lesions (left or right hemisphere), subcortical lesions or supra-pontic lesions of the corticospinal tract having caused paralysis of the upper limb as documented by radiologic evidence
* Adequate or corrected vision

Exclusion criteria:

* Any reason obstructing EEG acquisition (scalp infections or wounds, dermatitis, etc)
* Severe concomitant diseases (fever, infections, cardiac conditions, etc)
* Heavy medication affecting the central nervous system (CNS, especially vigilance)
* CVA with multiple infarcts
* Second or later CVA
* Severe unilateral hemispatial neglect as assessed by the behavioural part of the Behavioural Inattention Test (BIT) and the Fluff Test for body neglect
* Severe cognitive disability affecting speech production, communication (e.g. aphasia), the ability to understand and give clear and free informed consent and to fully understand and comply with protocol instructions. A score of above 22/30 of the Montreal Cognitive Assessment (MoCA) scale is advised Inability to concentrate for 2 consecutive hours
* Concomitant neurological conditions (e.g. Parkinson's disease) Severe spasticity. The Modified Ashworth Scale (MAS) score at the elbow, wrist and fingers should be below or equal to 2.
* Severe dystonia, dyskinesia or pain
* Cardiac pacemaker, active implants and other contraindications for FES
* Metallic implants affecting EEG acquisition

Patients for whom it is not possible to evoke a MEP greater than or equal to 0.2 mV amplitude at rest from the FDI and more proximal muscles (like ECR, FDS, etc) of the affected limb, or with contraindications for the TMS or Diffusion Tensor Imaging (DTI) protocols, will not undergo the respective procedures but will not be excluded from the trial.

Where it's running

  • Ospedale di Vipiteno | Azienda Sanitaria dell'Alto Adige
    Vipiteno, South Tyrol, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.